NCT07536815
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07536815
Title An Open-Label, Multicenter, Non-Randomized Expanded Access Protocol (EAP) Designed to Provide Leronlimab to Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (mTNBC)
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors CytoDyn, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Oregon Oncology Specialists AVAILABLE Salem Oregon 97301 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field